+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bronchitis Drugs Market Research Reports

From
Bronchitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
Levofloxacin Global Market Report 2024 - Product Thumbnail Image

Levofloxacin Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Bronchitis Treatment Global Market Report 2024 - Product Thumbnail Image

Bronchitis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Chronic Bronchitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Bronchitis Treatments: Global Markets - Product Thumbnail Image

Bronchitis Treatments: Global Markets

  • Report
  • November 2022
  • 98 Pages
  • Global
From
From
From
From
Loading Indicator

The Bronchitis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat bronchitis. Bronchitis is an inflammation of the bronchial tubes, which are the airways that carry air to and from the lungs. Bronchitis drugs are used to reduce inflammation, reduce mucus production, and improve breathing. Common bronchitis drugs include bronchodilators, corticosteroids, and antibiotics. Bronchitis drugs are sold by a variety of companies, including GlaxoSmithKline, Merck & Co., Pfizer, and AstraZeneca. These companies produce a range of bronchitis drugs, including Advair, Symbicort, and Flovent. Other companies, such as Boehringer Ingelheim, Novartis, and Sanofi, also produce bronchitis drugs. Show Less Read more